Higher rates of skin clearance and efficacy in challenging body areas are associated with better health-related quality of life following ixekizumab maintenance treatment in pediatric patients with plaque psoriasis.
Saved in:
| Title: | Higher rates of skin clearance and efficacy in challenging body areas are associated with better health-related quality of life following ixekizumab maintenance treatment in pediatric patients with plaque psoriasis. |
|---|---|
| Authors: | Hebert AA; The UTHealth McGovern Medical School, Houston, Texas, USA., Bobonich MA; CWRU Schools of Medicine and Nursing, Case Western Reserve University Cleveland, Cleveland, Ohio, USA., Rodriguez Capriles C; Eli Lilly and Company, Indianapolis, Indiana, USA., Gallo G; Eli Lilly and Company, Indianapolis, Indiana, USA., Li L; Eli Lilly and Company, Indianapolis, Indiana, USA., Somani N; Eli Lilly and Company, Indianapolis, Indiana, USA., Ridenour T; Eli Lilly and Company, Indianapolis, Indiana, USA., Wang Y; Eli Lilly and Company, Indianapolis, Indiana, USA., Edson-Heredia E; Eli Lilly and Company, Indianapolis, Indiana, USA., Becker EM; University of Texas Health Science Center San Antonio, San Antonio, Texas, USA. |
| Source: | Pediatric dermatology [Pediatr Dermatol] 2022 Jan; Vol. 39 (1), pp. 55-60. Date of Electronic Publication: 2021 Dec 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 8406799 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1470 (Electronic) Linking ISSN: 07368046 NLM ISO Abbreviation: Pediatr Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1525-1470 |
|---|---|
| DOI: | 10.1111/pde.14892 |
